Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Burn

Showing results (111-120 of 128) with videos related to

Pageof 13
Sort By:
British Journal of Cancer|July 23, 2022
Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testingOlaf Neumann, Timothy C Burn, Michael Allgäuer, et al.
The Journal of Biological Chemistry|January 5, 2002
Absence of post-translational aspartyl beta-hydroxylation of epidermal growth factor domains in mice leads to developmental defects and an increased incidence of intestinal neoplasiaJoseph E Dinchuk, Richard J Focht, Jennifer A Kelley, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 1997
Polycystin: in vitro synthesis, in vivo tissue expression, and subcellular localization identifies a large membrane-associated proteinO Ibraghimov-Beskrovnaya, W R Dackowski, L Foggensteiner, et al.
Journal of Medicinal Chemistry|July 16, 2021
Discovery of Pemigatinib: A Potent and Selective Fibroblast Growth Factor Receptor (FGFR) InhibitorLiangxing Wu, Colin Zhang, Chunhong He, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2010
Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050Jordan S Fridman, Peggy A Scherle, Robert Collins, et al.
Blood|March 4, 2010
Selective inhibition of IDO1 effectively regulates mediators of antitumor immunityXiangdong Liu, Niu Shin, Holly K Koblish, et al.
Plos One|April 22, 2020
INCB054828 (pemigatinib), a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays activity against genetically defined tumor modelsPhillip C C Liu, Holly Koblish, Liangxing Wu, et al.
Journal of Medicinal Chemistry|June 23, 2006
Potent benzimidazole sulfonamide protein tyrosine phosphatase 1B inhibitors containing the heterocyclic (S)-isothiazolidinone phosphotyrosine mimeticAndrew P Combs, Wenyu Zhu, Matthew L Crawley, et al.
ACS Medicinal Chemistry Letters|May 20, 2017
INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncologyEddy W Yue, Richard Sparks, Padmaja Polam, et al.
The Journal of Biological Chemistry|August 7, 1999
Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS familyI Abbaszade, R Q Liu, F Yang, et al.
Pageof 13

Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
British Journal of Cancer|July 23, 2022
Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testingOlaf Neumann, Timothy C Burn, Michael Allgäuer, et al.
The Journal of Biological Chemistry|January 5, 2002
Absence of post-translational aspartyl beta-hydroxylation of epidermal growth factor domains in mice leads to developmental defects and an increased incidence of intestinal neoplasiaJoseph E Dinchuk, Richard J Focht, Jennifer A Kelley, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 1997
Polycystin: in vitro synthesis, in vivo tissue expression, and subcellular localization identifies a large membrane-associated proteinO Ibraghimov-Beskrovnaya, W R Dackowski, L Foggensteiner, et al.
Journal of Medicinal Chemistry|July 16, 2021
Discovery of Pemigatinib: A Potent and Selective Fibroblast Growth Factor Receptor (FGFR) InhibitorLiangxing Wu, Colin Zhang, Chunhong He, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2010
Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050Jordan S Fridman, Peggy A Scherle, Robert Collins, et al.
Blood|March 4, 2010
Selective inhibition of IDO1 effectively regulates mediators of antitumor immunityXiangdong Liu, Niu Shin, Holly K Koblish, et al.
Plos One|April 22, 2020
INCB054828 (pemigatinib), a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays activity against genetically defined tumor modelsPhillip C C Liu, Holly Koblish, Liangxing Wu, et al.
Journal of Medicinal Chemistry|June 23, 2006
Potent benzimidazole sulfonamide protein tyrosine phosphatase 1B inhibitors containing the heterocyclic (S)-isothiazolidinone phosphotyrosine mimeticAndrew P Combs, Wenyu Zhu, Matthew L Crawley, et al.
ACS Medicinal Chemistry Letters|May 20, 2017
INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncologyEddy W Yue, Richard Sparks, Padmaja Polam, et al.
The Journal of Biological Chemistry|August 7, 1999
Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS familyI Abbaszade, R Q Liu, F Yang, et al.
Pageof 13